Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 16, 2014 08:43 ET | Source: Trinity Biotech plc

Trinity Biotech plc to Announce First Quarter Fiscal Year 2014 Financial Results

DUBLIN, April 16, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...
March 04, 2014 09:31 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Results for Q4 and Fiscal Year 2013

DUBLIN, March 4, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today...
February 19, 2014 08:07 ET | Source: Trinity Biotech plc

Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2013 Financial Results

DUBLIN, Feb. 19, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will...
January 29, 2014 08:27 ET | Source: Trinity Biotech plc

Trinity Biotech Announces European Approval of Guideline Compliant, Point-of-Care, High Sensitivity Troponin I Product

DUBLIN, Jan. 29, 2014 (GLOBE NEWSWIRE) -- Trinity Biotech plc. (Nasdaq:TRIB) today announced it has obtained the CE mark (i.e. European approval) for its Meritas, high sensitivity Troponin I (hsTnI)...
October 17, 2013 09:27 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Quarter 3 Financial Results, Acquisition of Blood Bank Screening Business and FDA Approval of HIV-2 Claim

DUBLIN, Ireland, Oct. 17, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
September 30, 2013 07:34 ET | Source: Trinity Biotech plc

Trinity Biotech plc to Announce Third Quarter Fiscal Year 2013 Financial Results

DUBLIN, Ireland, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
July 30, 2013 09:38 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Quarter 2 Financial Results and Acquisition of Immco Diagnostics Inc.

DUBLIN, Ireland, July 30, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
July 23, 2013 10:29 ET | Source: Trinity Biotech plc

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2013 Financial Results

DUBLIN, Ireland, July 23, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
April 25, 2013 08:34 ET | Source: Trinity Biotech plc

Trinity Biotech Announces Quarter 1 Results - EPS of 20 Cents, Premier Regulatory Approval in China and 33% Increase in Dividend to 20 Cents

DUBLIN, Ireland, April 25, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...
April 16, 2013 05:50 ET | Source: Trinity Biotech plc

Trinity Biotech plc to Announce First Quarter Fiscal Year 2013 Financial Results

DUBLIN, Ireland, April 16, 2013 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory...